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Abstract 
Nicotinic acetylcholine receptors (nAChRs) modulate synaptic activity in the central nervous 
system. The α7 subtype, in particular, has attracted considerable interest in drug discovery as 
a target for several conditions, including Alzheimer’s disease and schizophrenia. Identifying 
agonist-induced structural changes underlying nAChR activation is fundamentally important 
for understanding biological function and rational drug design. Here, extensive equilibrium and 
nonequilibrium molecular dynamics simulations, enabled by cloud-based high-performance 
computing, reveal the molecular mechanism by which structural changes induced by agonist 
unbinding are transmitted within the human α7 nAChR. The simulations reveal the sequence 
of coupled structural changes involved in driving conformational change responsible for 
biological function. Comparison with simulations of the α4β2 nAChR subtype identifies 
2 
 
features of the dynamical architecture common to both receptors, suggesting a general 
structural mechanism for signal propagation in this important family of receptors.  
 
 
Nicotinic acetylcholine receptors (nAChR) are prototypical members of the Cys loop 
pentameric ligand-gated ion channel (pLGICs) family, which also includes the GABAA and 5-
HT3 receptors.1-3 In the peripheral nervous system, nAChRs mediate fast excitatory synaptic 
signalling whereas in the brain they mostly modulate the synaptic signalling of a wide range of 
neurotransmitters.4 Neuronal nAChRs expressed in the CNS are putative targets for the 
treatment of a variety of neurodegenerative diseases, neurodevelopmental disorders, pain and 
addiction5, and analogous nAChRs in the insect CNS are targets for neonicotinoid pesticides.6 
The α7 subtype is one of most abundant nAChRs subtypes in the mammalian CNS5, attracting 
considerable interest for drug discovery due to its role in cognition, attention, memory and 
sensory processing.7 α7 nAChR dysfunction is implicated in disorders such as Alzheimer’s and 
Parkinson's diseases and schizophrenia.5 
There are many nAChR subtypes, distinguished by their specific combination of five subunits1-
3, 8. Despite differences in sequence (Figure S1), all subunits share the same basic architecture 
(Figure 1), consisting of a N-terminal extracellular domain (ECD), a transmembrane domain 
(TMD), a variable cytoplasmic domain (ICD) and a short extracellular C-terminal domain.1-3 
The structures of nAChRs (and other pLGICs) have been revealed by cryo-electron 
microscopy9-11 and X-ray crystallography12. The agonist-binding pockets are located in the 
ECDs at the interface between two neighbouring subunits (Figure 1). The α7 receptor subtype 
is unusual in being formed of five identical α7 subunits symmetrically arranged around a 
central ion channel1-3 and thus presents five equivalent binding pockets, lined by several highly 




Figure 1. Close-up view of the ligand-binding pocket of human α7 nAChR. A model for the α7 subtype was 
built using as a template the α4 subunit of the human α4β2 nAChR12. Nicotine was modelled in two 
nonconsecutive binding pockets, similar to what is observed in the human α4β2 nAChR structure12 (see 




Binding of acetylcholine (and other agonists such as nicotine) leads to opening of the ion 
channel, causing a flow of positive ions across the membrane, triggering depolarisation and 
signalling mechanisms.2,14 Several regions at ECD-TMD interface have been shown to be 
essential for linking the agonist binding site to the channel gate (e.g.15-25), namely the 10-M1 
region (which covalently links the ECD and TMD) and the Cys, F and 1-2 loops, which are 
in direct contact with the M2-M3 linker, a well-established gating control element.20,22,26-30 
However, while the application of a variety of experimental approaches has led to a greater 
insight into the function of nAChR, the conformational changes induced by agonist 
binding/unbinding and how those are communicated to the ion channel remain poorly defined.  
Answering this question requires knowledge of the dynamics of the protein and the temporal 
evolution of the conformational changes that take place upon ligand (un)binding. Biomolecular 
simulations have the potential to investigate these questions31, but face serious challenges 
associated with the large size of the systems and timescales involved; we show here that these 
can be overcome by the use of cloud-based high-performance computing (HPC) and by 
advanced, nonequilibrium molecular dynamics (MD) simulations, complementing standard 
equilibrium MD. In previous work on human α4β2 nAChR32, we demonstrated how a 
combination of equilibrium and nonequilibrium MD simulations identified the structural motifs 
involved in signal propagation upon nicotine unbinding and the sequence of the events 
associated with the first steps of this process. Here, we have applied this novel approach to the 
human α7 nAChR, using cloud-based nonequilibrium simulations to complement more 
traditional high-performance computing to achieve long timescales and extensive sampling. 
We identify the dynamic structural mechanism of receptor response to nicotine and, by 
comparison with the human α4β2 nAChR, we find a common signal propagation pathway in 
nAChRs, which may generally apply to pLGICs.  
Extensive equilibrium MD simulations (totalling 10 μs), with and without nicotine bound, were 
performed to identify the conformational changes induced by the ligand in the human α7 
nAChR receptor. These simulations show that nicotine induces conformational changes in the 
binding pocket region, namely in loop B and C and also at the ECD:TMD interface, namely in 
the Cys and F loops and in the M2-M3 linker (Figures S10-S13). These results correlate well 
with the experimental evidence indicating that loop B, C and F have a role in binding (e.g.33,34) 
and agonist affinity35,36. Structural changes are also observed in the second layer of residues 
surrounding the binding site, mainly in the extracellular selectivity filter region (Figure S14). 
Note that a despite some differences in amplitude, similar structural changes are observed 
between the two binding pockets (Figure S10-S11). Although loop F has been shown to be 
essential for binding13, its role in signal propagation remains elusive.37,38 In our nicotine-bound 
equilibrium simulations, the motions of the upper part of loop F (residues D186-Y190) are 
coupled to the movements of the ECDs (right-side panels in Figure S15-S16), mostly to the 
binding-site region (loops B, C and loop D). The dynamics of the lower part of loop F (residues 
P192-W196) are highly correlated with the ECDs (namely the loops A, B, C and D in the 
binding pockets and the Cys loop at the interface between domains) and the TMDs (namely 
transmembrane helices M1, M2 and M3 and the M2-M3 linker).  
When nicotine is present in the binding pockets, the dynamics of the M2-M3 linker is highly 
correlated not only with transmembrane helices 1, 2 and 3 but also with the Cys loop and some 
of the structural motifs forming the binding pockets, namely loops A, B and C (Figure S17). 
Several experimental studies have shown that mutations in the M2-M3 linker alter channel 
gating and disrupt the communication between domains in nAChRs (e.g.20,22,26,28-30,39,40) and in 
other pLGICs (e.g.27,41-45).  
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These simulations of human α7 nAChR, combined with results for the human α4β2 nAChR32, 
reveal a common pattern of nicotine-induced structural rearrangements. Despite the differences 
in sequences between the two receptors, including differences in the Cys, B and C loops and 
M2-M3 linker (Figures S1-S2), similar conformational changes are observed in these structural 
elements. The largest difference in behaviour between the subtypes occurs in loop A, which 
shows a significant rearrangement in α7 but not in the α4β2 subtype.  
Here, a set of 450 nonequilibrium simulations without nicotine was performed to identify the 
signal propagation pathway in the α7 nAChR. The equilibrium and nonequilibrium simulations 
are complementary approaches. The former allows for identification of the agonist-induced 
conformational changes (after hundreds of nanoseconds), while the latter allows for the 
determination of the order of the events associated with signal propagation and interdomain 
communication.  
In all nonequilibrium simulations performed, both nicotine molecules were instantaneously 
annihilated. These simulations reveal the response of the system to this perturbation, 
specifically showing the mechanical and dynamical coupling between structural elements 
involved in the response (Figures 2, S20-S22 and Movie 1). Note that the nonequilibrium 
simulations performed here do not imply free energy calculations (e.g.46-49). In this case, it is 
the introduction of a perturbation that forces the system out of equilibrium. The Kubo-Onsager 
approach pioneered by Ciccotti50-52 was used to compute the response of the receptor to 
nicotine removal (Figures S18-S19), by comparing the differences in the evolution of the 
simulations with and without nicotine, averaged over large numbers of simulations. The 
subtraction approach, and averaging over multiple (450) short simulations, allows 
conformational changes and their temporal sequence to be identified and their statistical 
significance to be determined. These nonequilibrium simulations are not intended to model the 
physical process of ligand (un)binding, nor the transition between states and, due to the 
artificial nature of the perturbation, the timescales observed for the response of the receptor do 
not represent the biological timescales.32 It is also important to note that, due to the short 
timescale of the nonequilibrium simulations (5 ns), the observed deviations reflect only the 





Figure 2- Signal propagation pathway from the ECD to the TMD in the α7 nAChR. Average Cα-positional 
deviation at times 0, 0.05, 0.5, 1, 3 and 5 ns following nicotine annihilation from the first binding pocket. The Cα 
deviations between the simulations with and without nicotine were determined for each residue, and the final 
values were averaged over the 450 pairs of simulations (Figure S18-S19). The Cα average deviations are mapped 
onto the average structure for the system without nicotine using the colour scheme in the scale on the right.  
 
The 450 nonequilibrium simulations were performed in five days using the Oracle Cloud and 
100 compute instances managed via cluster-in-the-cloud (https://cluster-in-the-
cloud.readthedocs.io and https://doi.org/10.5281/zenodo.3246253). Profiling cloud versus on-
premises computing suggested that these simulations would have taken around three months 
on shared local HPC resources. This demonstrates the rapid turnaround and throughput of high-
end scientific computation (in this case intensive, physics-based atomistic MD simulations) 
that is now possible using such cloud services. The approach here combines strengths of 
traditional HPC (for equilibrium simulations) with the cloud (for nonequilibirum simulations).  
The nonequilibrium simulations show that signal transmission in the α7 receptor starts in the 
binding pocket region, in loop C, and it then propagates to loop F and finally to the TMDs 
(Figure 2). Unsurprisingly, loop C (residues S206-Y217) is the first region to respond to ligand 
removal, and after 0.05 ns, some conformational rearrangements are already observed in this 
region. Over the next few nanoseconds, gradual and cumulative conformational changes 
propagate to the top (residues D186-Y190) and then to the lower part of loop F (residues P192-
W196) and afterwards to the TMDs via the M2-M3 linker (residues T286-V290) (Figures 2, 
S20-S21 and Movie 1). Note that the two binding pockets show similar responses to nicotine 
annihilation, with the same order of events observed for each (Figures S18-S19). All the 
structural motifs identified here have been shown experimentally to be involved in ligand 
binding and signal transduction: Loop C is important for binding (e.g.33,34), contributing to 
binding the ammonium group of the agonists13,53; Loop F plays a role in ligand binding affinity, 
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and specificity13; and the M2-M3 linker is essential for channel gating and communication 
between domains (e.g.22,26-30,39-45), and insertions/deletions of residues in this region directly 
affect the open-channel lifetime.30  
 
 
Figure 3- The ECD:TMD signal propagation pathway in human α7 and α4β2 nAChRs. The 
deviations for the α4β2 nAChR are taken from32. Note that although the apparent rate of propagation is 
different, the sequence of conformational changes associated with the initial steps of signal propagation 
is the same for both subtypes, i.e. the structural elements involved (loops C, F and M2-M3 linker), and 




The signal propagation pathway observed here for the α7 nAChR is remarkably similar to that 
of the α4β2 nAChR.32 The structural motifs involved in the signal transmission and the 
sequence of changes are the same between the two subtypes (Figure 3 and Movie 2). This 
supports the idea that, despite differences in sequence13,54, all family members share a common 
communication mechanism. Our simulations show differences in the rate of propagation, which 
may relate to differences in function and response between receptor subtypes. All known 
pLGICs have a similar molecular architecture1-3 and it has been shown experimentally that all 
of the structural elements identified here (loops C, F, Cys and the M2-M3 linker) are important 
not only in nAChR (e.g.15,20,22,26,28,30,39,40) but also in other homologous receptors (e.g.37,38,55-
58). Furthermore, it is also known that chimeric pLGICs formed by modular combinations of 
different ECDs and TMDs are still functional.21,59,60  
Our findings identify a general mechanism for communication within this receptor family: the 
structural rearrangements associated with signal propagation start in loop C and are 
subsequently transmitted, gradually and cumulatively, to loop F, and then to the TMDs via the 
M2-M3 linker. This mechanism is consistent with experimental data and provides a molecular-
level rationalisation of those data. This dynamic mechanism of signal propagation not only 
confirms the involvement of specific structural motifs but also shows, for the first time, the 
complex contribution of Loop F to signal propagation. It should also assist in the design of 
agonists or allosteric modulators to target nAChRs and other biomedically relevant pLGICs. 
The approach used here, combining extensive equilibrium and nonequilibrium simulations, is 
a valuable tool to study conformational changes in allosteric proteins.  
 
Supporting Information. [Detailed description of the methods, conformational stability of the 
α7 nAChR,  dynamic behaviour of the nicotine ligands, nicotine-induced conformational 
changes, nonequilibrium analysis] 
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